title: Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn's disease who refused colonoscopy or underwent incomplete colonoscopic exam: a case series.
abstract: BACKGROUND
  Almost 70-80 % of patients with Crohn's disease and virtually all patients with ulcerative colitis have colorectal mucosa involvement. Colon capsule endoscopy is an interesting option for patients unable or unwilling to undergo colonoscopy. We report our experience with the second-generation colon capsule PillCam(®) COLON 2 in the detection of significant lesions in patients with known or suspected Crohn's disease, who refused colonoscopy or underwent incomplete colonoscopic exam.
  
  
  METHODS
  We have retrospectively reviewed the results of capsule endoscopy in 6 patients who refused colonoscopy (n = 3) or underwent incomplete colonoscopic exam (n = 3) between March 2011 and October 2012. In all patients, a CT scan was obtained before capsule endoscopy to rule out significant stenosis.
  
  
  RESULTS
  In our series of 6 patients, 4 had both small bowel and colonic involvement. The use of the PillCam(®) COLON 2 capsule allowed a thorough examination and evaluation of the mucosal lesions with high acceptability, the method being perceived as noninvasive by the patients. No adverse events related to the capsule or bowel preparation were recorded.
  
  
  CONCLUSIONS
  In this patient population, PillCam(®) COLON 2 capsule endoscopy was safe. The capsule findings had an important impact on treatment decisions and patient management.
authors: Department of Internal Medicine 2-Gastroenterology, University Hospital, Carol Davila University of Medicine Bucharest, Bucharest, Romania, negreanu_99@yahoo.com.
authors: L
authors: L
authors: Negreanu
authors: G
authors: G
authors: Smarandache
authors: R B
authors: RB
authors: Mateescu
mesh_terms: D000328:Adult; D000368:Aged; D053704:Capsule Endoscopy; D003113:Colonoscopy; D003424:Crohn Disease / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016312:Treatment Refusal
references: J Dig Dis. 2013 Mar;14(3):117-24
references: 23134295
references: Endoscopy. 2009 Jul;41(7):618-37
references: 19588292
references: Gastroenterol Clin North Am. 2012 Jun;41(2):315-23
references: 22500520
references: Endoscopy. 2012 Aug;44(8):754-8
references: 22696193
references: Gastrointest Endosc. 2011 Jul;74(1):167-75
references: 21497806
references: Scand J Gastroenterol. 2009;44(10):1158-65
references: 19606392
references: J Crohns Colitis. 2010 Feb;4(1):28-62
references: 21122489
references: Gastrointest Endosc. 2010 Feb;71(2):280-6
references: 20152309
references: Tech Coloproctol. 2013 Dec;17(6):641-6
references: 23307507
references: Inflamm Bowel Dis. 2011 Sep;17(9):1855-62
references: 21830264
references: Am J Gastroenterol. 2010 Jun;105(6):1240-8; quiz 1249
references: 20029412
references: Dig Liver Dis. 2005 Feb;37(2):113-8
references: 15733524
references: Gastrointest Endosc. 2008 May;67(6):902-9
references: 18355824
references: Am J Gastroenterol. 2006 Oct;101(10):2218-22
references: 16848804
references: Dig Dis Sci. 2008 Oct;53(10):2732-8
references: 18320313
references: Endoscopy. 2012 May;44(5):527-36
references: 22389230
references: Endoscopy. 2007 Oct;39(10):895-909
references: 17968807
references: Curr Drug Targets. 2012 Sep 1;13(10):1252-60
references: 22664082
references: Gastrointest Endosc. 2011 Sep;74(3):581-589.e1
references: 21601200
references: N Engl J Med. 2009 Nov 19;361(21):2066-78
references: 19923578
references: Hepatogastroenterology. 2012 Mar-Apr;59(114):418-21
references: 22353508
references: Endoscopy. 2011 Feb;43(2):123-7
references: 21038293
references: Gastroenterol Res Pract. 2012;2012:518718
references: 21969823
references: Acta Chir Belg. 2010 Mar-Apr;110(2):213-5
references: 20514837